1. Home
  2. DXC vs LMAT Comparison

DXC vs LMAT Comparison

Compare DXC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DXC Technology Company

DXC

DXC Technology Company

HOLD

Current Price

$11.97

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$110.70

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXC
LMAT
Founded
1959
1983
Country
United States
United States
Employees
130000
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
DXC
LMAT
Price
$11.97
$110.70
Analyst Decision
Hold
Buy
Analyst Count
7
5
Target Price
$15.33
$105.80
AVG Volume (30 Days)
2.1M
256.9K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
0.91%
EPS Growth
356.52
30.57
EPS
0.88
2.52
Revenue
$12,871,000,000.00
$249,602,000.00
Revenue This Year
N/A
$14.01
Revenue Next Year
N/A
$8.61
P/E Ratio
$13.28
$43.70
Revenue Growth
N/A
13.53
52 Week Low
$11.54
$71.42
52 Week High
$17.68
$115.33

Technical Indicators

Market Signals
Indicator
DXC
LMAT
Relative Strength Index (RSI) 43.54 63.32
Support Level $11.72 $81.44
Resistance Level $15.58 $111.27
Average True Range (ATR) 0.40 3.48
MACD 0.05 -0.63
Stochastic Oscillator 24.09 72.92

Price Performance

Historical Comparison
DXC
LMAT

About DXC DXC Technology Company

DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: